Therefore, TRIM17 may be involved in the chemoresistance of cancer cells that exhibit a survival dependency on BCL2A1 whereas it would increase the sensitivity of tumors depending on MCL1, due to its opposite effects on these two antiapoptotic proteins (see above). Here, TRIM17 is linked to cancer.